The latest FTSE 100 reshuffle is set to see Abrdn, Hikma Pharmaceuticals, and Howden Joinery relegated from the index in favour of three other firms. According to market capitalisation data from Tuesday's closing prices, Abrdn's £2.3bn market value drop has put it at risk of demotion, while Hikma's share price fluctuations have led to a valuation of around £5.6bn. Similarly, Howden Joinery's market standing has been impacted by shifts in consumer spending and construction activity, bringing its market capitalisation to approximately £2.8bn.
The quarterly reshuffle, which occurs every three months, is based on the companies' overall market value and ensures that the FTSE 100 remains a relevant indicator of the UK's largest listed companies. With Abrdn's exit potentially marking the end of an era for one of Scotland's most prominent financial institutions, investors will be closely monitoring its replacement in the index.
The confirmation of these changes is expected soon, with the new constituents taking effect shortly thereafter. The affected stocks are likely to see increased trading volumes and short-term price movements as passive investment funds and ETFs adjust their holdings to reflect the updated index composition.